Botulinum toxin type A

Therapeutic indications

Botulinum toxin type A is indicated for:

Blepharospasm, hemifacial spasm

Population group: only adults (18 years old or older)

at least one of
Blepharospasm
Hemifacial spasm

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Idiopathic cervical dystonia (spasmodic torticollis)

Population group: only adults (18 years old or older)

Spasmodic torticollis

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Focal spasticity of the upper limb in ambulant paediatric cerebral palsy patients

Population group: only children (1 year - 12 years old)

Botulinum toxin type A is indicated for treatment of focal spasticity of ankle and foot in ambulant paediatric cerebral palsy patients, two years of age or older as an adjunct to rehabilitative therapy.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Upper limb spasticity associated with stroke

Population group: only adults (18 years old or older)

Botulinum toxin type A is indicated for wrist and hand disability due to upper limb spasticity associated with stroke in adults.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Primary hyperhidrosis of the axillae

Population group: only adults (18 years old or older)

Botulinum toxin type A is indicated for the management of severe hyperhidrosis of the axillae, which does not respond to topical treatment with antiperspirants or antihidrotics.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Focal lower limb spasticity associated with stroke in adults

Population group: only children (1 year - 12 years old) , adolescents (12 years - 18 years old)

Botulinum toxin type A is indicated for ankle and foot disability due to lower limb spasticity associated with stroke in adults.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Overactive bladder

Population group: only adults (18 years old or older)

Overactive bladder with symptoms of urinary incontinence, urgency and frequency in adult patients who are not adequately managed with anticholinergics.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Urinary incontinence due to neurogenic detrusor overactivity

Population group: only adults (18 years old or older)

Incontinence due to detrusor instability

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Chronic migraine

Population group: only adults (18 years old or older)

Prophylaxis of headaches in adults with chronic migraine (headaches on at least 15 days per month of which at least 8 days are with migraine).

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Focal spasticity of the upper limb in paediatric cerebral palsy patients

Population group: only children (1 year - 12 years old)

Botulinum toxin type A is indicated for the treatment of focal spasticity of elbow, wrist and hand in paediatric cerebral palsy patients, two years of age or older as an adjunct to rehabilitative therapy.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Glabellar lines seen at maximum frown

Population group: only adults (18 years old or older)

Rhytide of glabellar skin

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Crow’s feet lines seen at maximum smile

Population group: only adults (18 - 65 years old)

Crow's feet

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Forehead lines seen at maximum eyebrow elevation

Population group: only adults (18 - 65 years old)

Rhytide of forehead

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Botulinum toxin type A is contraindicated in the following cases:

Pregnancy

Pregnancy

Lactation

Lactation

Presence of infection at the proposed injection site(s)

Infectious disease

Urinary tract infection, acute urinary retention, patients not initiating catheterisation post-treatment, bladder calculi

at least one of
Urinary tract infectious disease
Acute retention of urine
Urinary bladder stone

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Structured Product Labeling (SPL/PLR) 2021: XEOMIN Powder for solution for injection
Summary of Product Characteristics (SPC) 2022: BOTOX Powder for solution for injection
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈